Navigation Links
Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
Date:2/22/2010

Business Outlook and Guidance

"Improving our operational efficiency, building our pipeline and strengthening our management team are expected to be our top priorities right now," said Mr. Cao. "We are already taking steps to address these challenges and look forward to providing updates on our progress."

Jiangbo's management has begun reviewing the existing marketing and sales system, including sales force compensation and incentive and effectiveness of our advertising activities. The Company is planning to take steps to reduce and eliminate operational inefficiencies and drive sales growth.

The Company recognizes the need to improve its product pipeline in order to ensure long term growth. In the past several months, the Company has been actively searching for new branded drug opportunities to license or acquire. Management expects revenues to improve in the second half of fiscal 2010. As such, the Company is maintaining its fiscal 2010 revenue guidance of $96 million to $98 million and operating income guidance of $42 million to $44 million.

'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
2. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
3. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
5. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 6, 2015  Ascendant Solutions, Inc. (Pink Sheets: ... its results for the fourth quarter and year ended ... of $105,000, or less than $0.01 per share, on ... 2014.  This compares with net income of $195,000, or ... fourth quarter of 2013. The substantial increase in fourth ...
(Date:3/6/2015)... 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in ... cancer, today announced that James A. Joyce , ... corporate overview at the 27th Annual ROTH Conference on ... was previously scheduled to present at 5:30 pm Pacific ... held at The Ritz-Carlton Hotel in Laguna ...
(Date:3/6/2015)... March 6, 2015  The German Court of Appeal has ... ) vitamin regimen patent for Alimta® (pemetrexed disodium) would not ... a dipotassium salt form of pemetrexed in Germany ... The German Court ruled in favor of ... Company v. Actavis. This decision vacated the prior decision of ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 2Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 3Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 4Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 5Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 3
(Date:3/6/2015)... Ticket Down is a reputable source for authentic ... Center. After being away from the touring business for ... of letting up on his “Garth Brooks World Tour.” The ... Yearwood, to venues around the United States. The duo recently ... to the Moda Center in Portland, OR. The husband and ...
(Date:3/6/2015)... San Jose, California (PRWEB) March 06, 2015 ... testing, also known as the pharmacokinetics of a drug ... of a pharmaceutical compound inside an organism. When toxicity ... as ADME-Tox or ADMET or ADME/Tox. Increasing focus on ... the adoption of ADME-toxicology testing worldwide. The traditional drug ...
(Date:3/6/2015)... 2015 As the Muscular Dystrophy Association ... the organization has hired two new Scientific Program Officers, ... will report to Grace Pavlath, Ph.D, who joined MDA ... Program Director, and together will lead MDA as it ... cures for various types of neuromuscular and motor neuron ...
(Date:3/6/2015)... 2015 “On Tap” takes the audience on ... stage, to the silver screen and to modern day rhythm ... numbers and their famous eye-high kicks! Producers, directors and choreographers ... of tap dancing in this robust show, showcasing one of ... United States. , “On Tap” is proud to host ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 US Sports ... three Maryland camps – two non-contact specialty camps and ... run by Perfect Performance Training, located at Bowie State ... on developing position specific skills, speed and strength of ... at Salisbury University with Marvin Graves, former quarterback in ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:US Sports Camps to Host Three New Football Camps in Maryland 2
... a genetic disorder of the connective tissue is more ... ,"It's very important to recognize this condition ... Harry Dietz, director of Johns Hopkins University School of ... this process could save many people from an `avoidable ...
... to detect human bocavirus (HboV) infections in children living in ... this is the first confirmed case of HboV in the ... for Disease Control and Prevention (CDC) said, that 6 of ... around the ages of 12 months or younger have tested ...
... million pounds (Rs.21.94 million) initiative to support India's reproductive ... lives// every year. ,The 252 million pound ... (DFID) is to be Britain's single biggest response to ... ,The funds will be spent over five years ...
... feel or intuition is fleeting that we could use it in ... to research in this area. Researchers say that impressions// are formed ... needs is just a split second to size up a person’s ... ,With the help of timed experiments, participants were ...
... Minister Manmohan Singh Wednesday urged parliamentarians to help create ... the social and// economic burdens imposed by diseases like ... particular emphasis on the control of AIDS because in ... prevent the openness in discussions on matters relating to ...
... disorder, called Apnea, which could lead to learning and ... has// indicated that in certain cases it could lead ... has pinpointed that children with severe Apnea also termed ... memory retention abilities and language skills in comparison with ...
Cached Medicine News:Health News:PM Stresses Need for More Awareness on Human Sexuality 2
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... of infectious disease ELISA products make us ... assay protocols for faster integration into the ... provide increased reliability and run-to-run consistency. Our ... assays for a wide range of serological ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
Medicine Products: